CompletedPhase 1NCT00003294
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Roswell Park Cancer Institute
- Principal Investigator
- Gary N. Schwartz, MDNorris Cotton Cancer Center
- Intervention
- filgrastim(biological)
- Enrollment
- 24 enrolled
- Eligibility
- All sexes
- Timeline
- 1997 – 2004
Study locations (1)
- Roswell Park Cancer Institute, Buffalo, New York, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003294 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.